Literature DB >> 15765441

Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers.

Katrina F Trivers1, Anneclaire J De Roos, Marilie D Gammon, Thomas L Vaughan, Harvey A Risch, Andrew F Olshan, Janet B Schoenberg, Susan T Mayne, Robert Dubrow, Janet L Stanford, Page Abrahamson, Heidi Rotterdam, A Brian West, Joseph F Fraumeni, Wong-Ho Chow.   

Abstract

BACKGROUND AND AIMS: Risk factors for subtypes of esophageal and gastric cancer recently have been identified, but their effect on survival is unknown.
METHODS: Incident cases (n = 1142) from a population-based case-control study were followed-up from diagnosis (1993-1995) until 2000. Cox regression models were used to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for esophageal and gastric cancer in relation to prediagnostic factors.
RESULTS: Relative to distant stage, esophageal adenocarcinoma (EA) patients with localized disease had a decreased risk for death (HR, .22; 95% CI, .15-.31), followed by those with regional spread (HR, .32; 95% CI, .23-.45). Similar patterns were seen for the other tumor types. Except for other (non-cardia) gastric adenocarcinomas (OGA), higher household income (> or =15,000 US dollars/y vs. <15,000 US dollars/y) was associated with a 33%-38% decrease in risk for death. Prediagnosis body mass index (BMI) between 25 and 29.9 kg/m 2 was associated with longer survival for EA and OGA patients (EA: HR, .67; 95% CI, .51-.88) vs. BMI <25 kg/m(2). Women with esophageal squamous cell carcinoma (ES) and OGA experienced longer survival compared with men. Age, education, cigarette smoking, alcohol intake, gastroesophageal reflux disease, and nonsteroidal anti-inflammatory drug use did not consistently predict survival.
CONCLUSIONS: Predictors of lengthened esophageal and gastric cancer survival included higher income (except in OGA), overweight (among EA and OGA patients), and female sex (among ES and OGA patients).

Entities:  

Mesh:

Year:  2005        PMID: 15765441     DOI: 10.1016/s1542-3565(04)00613-5

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  30 in total

1.  Circulating MicroRNAs in Relation to Esophageal Adenocarcinoma Diagnosis and Survival.

Authors:  Jessica L Petrick; Ruth M Pfeiffer; Linda M Liao; Christian C Abnet; Xiaolin Wu; Marilie D Gammon; Thomas L Vaughan; Michael B Cook
Journal:  Dig Dis Sci       Date:  2021-01-06       Impact factor: 3.199

2.  Prediagnostic smoking and postoperative survival in lymph node-negative esophagus squamous cell carcinoma patients.

Authors:  Yongbin Lin; Xiaodong Su; Hongyu Su; Peng Lin; Hao Long; Lanjun Zhang; Jianhua Fu; Tiehua Rong; Zihui Tan; Yuqi Meng; Guowei Ma
Journal:  Cancer Sci       Date:  2012-10-09       Impact factor: 6.716

3.  Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature.

Authors:  Jessica L Petrick; Nan Li; Kathleen M McClain; Susan E Steck; Marilie D Gammon
Journal:  Curr Nutr Rep       Date:  2015-03-01

4.  Impact of body mass index on survival of esophageal squamous carcinoma patients in southern China.

Authors:  Chao Ren; Xiu-Yu Cai; Miao-Zhen Qiu; De-Shen Wang; Feng-Hua Wang; Hui-Yan Luo; Rui-Hua Xu
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

5.  An elevated body mass index does not reduce survival after esophagectomy for cancer.

Authors:  Marcovalerio Melis; Jill M Weber; James M McLoughlin; Erin M Siegel; Sarah Hoffe; Ravi Shridhar; Kiran K Turaga; George Dittrick; E Michelle Dean; Richard C Karl; Kenneth L Meredith
Journal:  Ann Surg Oncol       Date:  2010-09-24       Impact factor: 5.344

6.  A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the USA.

Authors:  Nan Li; Jessica L Petrick; Susan E Steck; Patrick T Bradshaw; Kathleen M McClain; Nicole M Niehoff; Lawrence S Engel; Nicholas J Shaheen; Harvey A Risch; Thomas L Vaughan; Anna H Wu; Marilie D Gammon
Journal:  Int J Epidemiol       Date:  2017-12-01       Impact factor: 7.196

7.  Survival after neoadjuvant therapy compared with surgery alone for resectable esophageal cancer in a population-based study.

Authors:  Ioannis Rouvelas; Wenyi Zeng; Mats Lindblad; Pernilla Viklund; Weimin Ye; Jesper Lagergren
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

8.  Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression.

Authors:  Jonine D Figueroa; Mary Beth Terry; Marilie D Gammon; Thomas L Vaughan; Harvey A Risch; Fang-Fang Zhang; David E Kleiner; William P Bennett; Christine L Howe; Robert Dubrow; Susan T Mayne; Joseph F Fraumeni; Wong-Ho Chow
Journal:  Cancer Causes Control       Date:  2008-11-07       Impact factor: 2.506

9.  Does Quality of Care Matter? A Study of Adherence to National Comprehensive Cancer Network Guidelines for Patients with Locally Advanced Esophageal Cancer.

Authors:  Daniela Molena; Benedetto Mungo; Miloslawa Stem; Amy K Poupore; Sophia Y Chen; Anne O Lidor
Journal:  J Gastrointest Surg       Date:  2015-08-06       Impact factor: 3.452

10.  Trends and variation in the management of oesophagogastric cancer patients: a population-based survey.

Authors:  Georgios Lyratzopoulos; Josephine M Barbiere; Chetna Gajperia; Michael Rhodes; David C Greenberg; Karen A Wright
Journal:  BMC Health Serv Res       Date:  2009-12-15       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.